ImageneBio Inc (IMA)

• Market cap: $63M
• 1 day: -1.05%
• 5 days: -10.63%
• 1 month: -13.52%
• 3 months: -4.58%
• 6 months: -29.18%
• Year to date: -16.72%
• 1 year: -66.25%
• 5 years: -98.53%
• 10 years: -98.53%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Employees: 15